AEGON Asset Management (UK)’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-403,461
Closed -$7.01M 179
2020
Q4
$7.01M Buy
403,461
+151,573
+60% +$2.42M 0.1% 108
2020
Q3
$3.47M Sell
251,888
-506,256
-67% -$7.44M 0.07% 98
2020
Q2
$10.9M Buy
758,144
+253,338
+50% +$3.33M 0.25% 77
2020
Q1
$5.51M Buy
+504,806
New +$9.31M 0.16% 83
2018
Q1
Sell
-140,262
Closed -$2.63M 191
2017
Q4
$2.63M Buy
+140,262
New +$2.79M 0.07% 102

Other funds holding SBRA

AEGON Asset Management (UK)'s SBRA Position: Q1 2021 in Review

AEGON Asset Management (UK) sold out of Sabra Healthcare REIT (SBRA) in Q1 2021, closing a stake of 403,461 shares — an estimated $7.01M sold.

AEGON Asset Management (UK) first reported a position in SBRA in Q4 2017 and held it in 5 quarters. The position peaked at $10.9M in Q2 2020. 333 funds tracked by Wall St. Rank hold SBRA as of Q1 2021.

  • AEGON Asset Management (UK) reported no remaining Sabra Healthcare REIT position as of Q1 2021 after selling out during the quarter.
  • AEGON Asset Management (UK) sold 403,461 Sabra Healthcare REIT shares in Q1 2021, an estimated $7.01M.
  • AEGON Asset Management (UK) first reported a position in Sabra Healthcare REIT in Q4 2017 and held it in 5 quarters.
  • AEGON Asset Management (UK)'s Sabra Healthcare REIT position peaked at $10.9M in Q2 2020.
  • 333 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2021.

Based on AEGON Asset Management (UK)'s 13F filing for Q1 2021, filed 7 May 2021.